An evaluation of the cardiotoxicity of imatinib mesylate

被引：51
|
作者：
Ribeiro, Antonio Luiz [1 ,2 ]
Marcolino, Milena Soriano [1 ]
Bittencourt, Henrique N. S. [1 ,3 ]
Barbosa, Marcia M. [4 ]
Nunes, Maria do Carmo P. [1 ,2 ]
Xavier, Vitor Fonseca [1 ]
Clementino, NeIrna C. D. [1 ,3 ]
机构：
[1] Univ Fed Minas Gerais, Hosp Clin, Sch Med, BR-30130100 Belo Horizonte, MG, Brazil
[2] Univ Fed Minas Gerais, Hosp Clin, Serv Cardiol, BR-30130100 Belo Horizonte, MG, Brazil
[3] Univ Fed Minas Gerais, Hosp Clin, Hematol Serv, BR-30130100 Belo Horizonte, MG, Brazil
[4] Hosp Socor, BR-30110075 Belo Horizonte, MG, Brazil
来源：
LEUKEMIA RESEARCH | 2008年 / 32卷 / 12期
关键词：
Imatinib; Cardiotoxicity; Chronic myeloid leukaemia; Ventricular function; BNP;
D O I：
10.1016/j.leukres.2008.03.020
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
We studied 103 consecutive patients with chronic myeloid leukaemia on treatment with imatinib (IM) and 57 patients with chronic myeloproliferative disorders not treated with IM in order to evaluate its cardiotoxicity. There was no statistical difference regarding cardiac symptoms and signs, BNP levels and echocardiographic measurements for IM and control groups, except for peripheral oedema, more frequent in the IM group. Four patients in the IM group presented a BNP level >100 pg/ml, one of them with depressed LVEF. IM was not related to systematic deterioration of cardiac function, but there is still a possibility of isolated cases of cardiotoxicity. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码：1809 / 1814
页数：6
相关论文
共 50 条
  • [41] Imatinib mesylate in cutaneous melanoma
    Redondo, P
    Lloret, P
    Andreu, EJ
    Inoges, S
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 123 (06) : 1208 - 1209
  • [42] Imatinib mesylate (Gleevec) hepatotoxicity
    Mindikoglu, Ayse L.
    Regev, Arie
    Bejarano, Pablo A.
    Martinez, Enrique J.
    Jeffers, Lennox J.
    Schiff, Eugene R.
    DIGESTIVE DISEASES AND SCIENCES, 2007, 52 (02) : 598 - 601
  • [43] Pneumatosis intestinalis and imatinib mesylate
    Ciara O’Rafferty
    Fiona McElligott
    Lorna Storey
    Aengus O’Marcaigh
    Owen Smith
    Annals of Hematology, 2014, 93 : 1783 - 1784
  • [44] An evaluation of a novel nanoformulation of imatinib mesylate in a mouse model of lupus nephritis
    Fogueri, Uma
    Charkoftaki, Georgia
    Roda, Gavriel
    Tuey, Stacey
    Ibrahim, Mustafa
    Persaud, Indushekhar
    Wempe, Michael F.
    Brown, Jared M.
    Thurman, Joshua M.
    Anchordoquy, Thomas J.
    Joy, Melanie S.
    DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2022, 12 (06) : 1445 - 1454
  • [45] CT evaluation of gastrointestinal stromal tumors treated with imatinib mesylate - Reply
    Choi, H
    Johnson, MM
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2005, 185 (05) : 1366 - 1367
  • [46] An evaluation of a novel nanoformulation of imatinib mesylate in a mouse model of lupus nephritis
    Uma Fogueri
    Georgia Charkoftaki
    Gavriel Roda
    Stacey Tuey
    Mustafa Ibrahim
    Indushekhar Persaud
    Michael F. Wempe
    Jared M. Brown
    Joshua M. Thurman
    Thomas J. Anchordoquy
    Melanie S. Joy
    Drug Delivery and Translational Research, 2022, 12 : 1445 - 1454
  • [47] Imatinib mesylate in metastatic chordoma
    Kunitz, A.
    Gebauer, B.
    Sturm, I
    ONKOLOGIE, 2010, 33 : 177 - 177
  • [48] Mechanisms of resistance to imatinib mesylate
    Roche-Lestienne, Catherine
    Preudhomme, Claude
    HEMATOLOGIE, 2006, 12 : 11 - 18
  • [49] Imatinib mesylate and cardiac function
    Luciano, L.
    Cerchione, C.
    Becchimanzi, C.
    Pane, F.
    Rotoli, B.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 182 - 182
  • [50] Berberine hydrochloride alleviates imatinib mesylate - induced cardiotoxicity through the inhibition of Nrf2-dependent ferroptosis
    Song, Chengzhu
    Li, Dongning
    Zhang, Jie
    Zhao, Xiaoyan
    FOOD & FUNCTION, 2023, 14 (02) : 1087 - 1098
12345